ESC 365 - Early atrial fibrillation ablation improves outcome as compared to initial treatment with antiarrhythmic drugs - PRO

EHRA Premium Access

Early atrial fibrillation ablation improves outcome as compared to initial treatment with antiarrhythmic drugs - PRO

Session: Controversies in atrial fibrillation ablation

Topic: Atrial Fibrillation - Treatment

Speaker: Professor P. Sanders (Adelaide, AU)

Event: EHRA 2018

Congress Presentation

About the speaker

Professor Prashanthan Sanders

University of Adelaide, Adelaide (Australia)

18 presentations

0 follower

12 more presentations in this session

Welcome video

Opening question

Isolation of pulmonary veins, is sufficient in patients with persistent AF? - PRO

Speaker: Doctor G. Fenelon (Sao Paulo, BR)

Isolation of pulmonary veins, is sufficient in patients with persistent AF? - CON

Speaker: Professor J. Kautzner (Prague, CZ)

Isolation of pulmonary veins, is sufficient in patients with persistent AF? - Rebuttal PRO

Access the full session

Controversies in atrial fibrillation ablation

Speakers: Professor P. Sanders, Doctor G. Fenelon, Professor J. Kautzner

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources